Learning how well a combination cancer treatment works in Japanese men

This is a research study that follows Japanese men with prostate cancer that has spread to a small number of bones. The study observes how well darolutamide works when combined with two other standard cancer treatments (hormone therapy and chemotherapy) that doctors are already prescribing. Researchers will review your medical records over one year to understand how safe and effective this combination is for patients like you.

Darolutamide combined with hormone therapy and chemotherapy is already approved for other types of prostate cancer, but doctors need to learn more about how well it works specifically for men with early-stage spread (low-volume metastatic disease). This study will help doctors make better treatment choices for patients in Japan with your type of cancer.